Table 2.
Correlations between COL10A1 mRNA levels and clinical-pathological parameters of gastric cancer patients
| Variable | Patient no. | COL10A1 mRNA | P-value | |
|---|---|---|---|---|
| Low no.(%) | High no.(%) | |||
| Gender | ||||
| Male | 72 | 37(51.4) | 35(48.6) | 0.562 |
| Female | 31 | 14(45.2) | 17(54.8) | |
| Age(years) | ||||
| <60 | 63 | 36(57.1) | 27(42.9) | 0.052 |
| ≥60 | 40 | 15(37.5) | 25(62.5) | |
| Tumor size | ||||
| <5 cm | 62 | 38(61.3) | 24(38.7) | 0.003 |
| ≥5 cm | 41 | 13(31.7) | 28(68.3) | |
| Differentiation | ||||
| Well | 31 | 21(67.7) | 10(32.3) | 0.052 |
| Moderate | 40 | 17(42.5) | 23(57.5) | |
| Poor | 32 | 13(40.6) | 19(59.4) | |
| Lymphatic emboli | ||||
| No | 59 | 36(61.0) | 23(39.0) | 0.007 |
| Yes | 44 | 15(34.1) | 29(65.9) | |
| Lymph node metastasis | ||||
| No | 43 | 32(74.4) | 11(25.6) | 0.000 |
| Yes | 60 | 19(31.7) | 41(68.3) | |
| Serosel invasion | ||||
| No | 44 | 29(65.9) | 15(34.1) | 0.004 |
| Yes | 59 | 22(37.3) | 37(62.7) | |
| AJCC stage | ||||
| Early | 48 | 33(68.8) | 15(31.2) | 0.000 |
| Advanced | 55 | 18(32.7) | 37(67.3) | |
| Recurrence | ||||
| No | 58 | 37(63.8) | 21(36.2) | 0.001 |
| Yes | 45 | 14(31.1) | 31(68.9) | |
Early stage included stage I (n = 26) and stage II (n = 22). Advanced stage included stage III (n = 41) and stage IV (n = 14)